TENAX THERAPEUTICS, INC.

TENX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.4B · 16 employees
387
SEC Filings
$1.83
Close 2026-10-12
16
Employees

Business Summary

Tenax Therapeutics is a Phase 3, development-stage pharmaceutical company focused on developing novel cardiopulmonary therapies. Its prioritized product candidate is oral levosimendan (TNX-103), currently in two Phase 3 clinical trials (LEVEL and LEVEL-2) for pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF). The company has also deprioritized a Phase 3 trial of imatinib for pulmonary hypertension. Both drugs are already approved in other indications worldwide. Tenax has no approved products currently on the market.

Latest Stock Quote

TENX 2026-10-12 $1.83 O:$1.88 H:$1.88 L:$1.83 Vol:0.8M VWAP:$1.8473
origin leaf: null

Next Earnings

expected 2027-01-07

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001193125-26-099393EDGAR47K words
2025-03-252024-12-310000950170-25-044398EDGAR46K words
2024-03-282023-12-310001654954-24-003827EDGAR62K words
2023-03-312022-12-310001654954-23-003945EDGAR55K words
2022-03-292021-12-310001654954-22-004036EDGAR54K words
2021-03-312020-12-310001654954-21-003641EDGAR46K words
2020-03-302019-12-310001654954-20-003498EDGAR39K words
2019-04-012018-12-310001654954-19-003861EDGAR39K words
2018-04-022017-12-310001654954-18-003517EDGAR41K words
2017-03-162016-12-310001654954-17-002098EDGAR56K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-07-312026-06-300001193125-26-327455EDGAR14K words
2025-11-122025-09-300001193125-25-277793EDGAR14K words
2025-08-132025-06-300000950170-25-108063EDGAR14K words
2025-05-142025-03-310000950170-25-071395EDGAR12K words
2024-11-132024-09-300001654954-24-014262EDGAR20K words
2024-08-132024-06-300001654954-24-010456EDGAR19K words
2024-05-142024-03-310001654954-24-006228EDGAR17K words
2023-11-132023-09-300001654954-23-014168EDGAR19K words
2023-08-142023-06-300001654954-23-010758EDGAR18K words
2023-05-152023-03-310001654954-23-006566EDGAR17K words
2022-11-102022-09-300001654954-22-015030EDGAR20K words
2022-08-112022-06-300001654954-22-011073EDGAR19K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-080001193125-26-417939EDGAR5K words
2026-09-090001193125-26-385910EDGAR4K words
2026-08-100001193125-26-341236EDGAR2K words
2026-07-310001193125-26-326784EDGAR2K words
2026-03-100001654954-26-002072EDGAR1K words
2026-01-090001654954-26-000232EDGAR1K words
2025-12-170001654954-25-014059EDGAR1K words
2025-11-120001654954-25-012921EDGAR2K words
2025-09-160001654954-25-010792EDGAR1K words
2025-09-090001654954-25-010510EDGAR2K words

387 total filings indexed. 355 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

pulmonary-hypertension heart-failure-with-preserved-ejection-fraction-(hfpef) cardiopulmonary-therapeutics pharmaceutical-drug-development

Company Identity

CIK0000034956
TickerTENX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.tenaxthera.com
Listed1995-02-01

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 89480aed9782dd770cbbfd92a49917f7735053554c986572b734ca1e6026458d
parent: 5a5e93ba6ddfe750fca9375d346664a6a0e5b0386782f092543cc01c34e05f40
content hash: b556ed33e92c418f64a3ec6c81a89916a9c308bad48a7426410feb61ceaf52cb
signed: 2026-10-13T19:03:25.153Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up TENX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on TENX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/TENX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.